260 related articles for article (PubMed ID: 12147888)
1. Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty.
Bajpai A; Sharma J; Kabra M; Gupta AK; Menon PS
Indian Pediatr; 2002 Jul; 39(7):633-9. PubMed ID: 12147888
[TBL] [Abstract][Full Text] [Related]
2. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
Paterson WF; McNeill E; Young D; Donaldson MD
Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone release hormone (D-Tryp6-GnRH) in monthly injections. Its possible use in normal puberty.
Marcondes JA; Abujamra AC; Minanni SL; Mendonca BB; Nery M; Lerario AC; Pereira MA; Abelin N; Wajchenberg BL
Horm Metab Res; 1993 Feb; 25(2):105-9. PubMed ID: 8458605
[TBL] [Abstract][Full Text] [Related]
4. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
Léger J; Reynaud R; Czernichow P
J Pediatr; 2000 Dec; 137(6):819-25. PubMed ID: 11113839
[TBL] [Abstract][Full Text] [Related]
5. Prolonged vaginal bleeding during central precocious puberty therapy with a long-acting gonadotropin-releasing hormone agonist.
Yeshaya A; Kauschansky A; Orvieto R; Varsano I; Nussinovitch M; Ben-Rafael Z
Acta Obstet Gynecol Scand; 1998 Mar; 77(3):327-9. PubMed ID: 9539281
[TBL] [Abstract][Full Text] [Related]
6. Growth, bone maturation and height prediction after three years of therapy with the slow release GnRH-agonist Decapeptyl-Depot in children with central precocious puberty.
Hümmelink R; Oostdijk W; Partsch CJ; Odink RJ; Drop SL; Sippell WG
Horm Metab Res; 1992 Mar; 24(3):122-6. PubMed ID: 1533604
[TBL] [Abstract][Full Text] [Related]
7. Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious Puberty.
Carel JC; Roger M; Ispas S; Tondu F; Lahlou N; Blumberg J; Chaussain JL
J Clin Endocrinol Metab; 1999 Jun; 84(6):1973-8. PubMed ID: 10372696
[TBL] [Abstract][Full Text] [Related]
8. Body mass index and body composition in adolescents treated with gonadotropin-releasing hormone analogue triptorelin depot for central precocious puberty: data at near final height.
Chiocca E; Dati E; Baroncelli GI; Mora S; Parrini D; Erba P; Bertelloni S
Neuroendocrinology; 2009; 89(4):441-7. PubMed ID: 19176945
[TBL] [Abstract][Full Text] [Related]
9. Combined use of growth hormone and gonadotropin-releasing hormone analogue in short normal adolescent girls: a survey from Iran.
Karamizadeh Z; Kashef MA; Jalaeian H; Namazee N
Kaohsiung J Med Sci; 2006 Apr; 22(4):161-5. PubMed ID: 16679296
[TBL] [Abstract][Full Text] [Related]
10. [Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].
Chen SK; Fan X; Tang Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):374-6. PubMed ID: 19470261
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole.
Almeida MQ; Brito VN; Lins TS; Guerra-Junior G; de Castro M; Antonini SR; Arnhold IJ; Mendonca BB; Latronico AC
Clin Endocrinol (Oxf); 2008 Jul; 69(1):93-8. PubMed ID: 18088394
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty.
Arrigo T; Cisternino M; Galluzzi F; Bertelloni S; Pasquino AM; Antoniazzi F; Borrelli P; Crisafulli G; Wasniewska M; De Luca F
Eur J Endocrinol; 1999 Aug; 141(2):140-4. PubMed ID: 10427157
[TBL] [Abstract][Full Text] [Related]
13. Treatment of central precocious puberty.
Kaplowitz PB
Curr Opin Endocrinol Diabetes Obes; 2009 Feb; 16(1):31-6. PubMed ID: 19104235
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of central precocious puberty with an LHRH analog. Effect on growth and bone maturation after 2 years of treatment].
Brauner R; Rappaport R
Arch Fr Pediatr; 1987 Apr; 44(4):271-6. PubMed ID: 3109347
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous gonadotropin-releasing hormone agonist (triptorelin) test for diagnosing precocious puberty.
Poomthavorn P; Khlairit P; Mahachoklertwattana P
Horm Res; 2009; 72(2):114-9. PubMed ID: 19690429
[TBL] [Abstract][Full Text] [Related]
16. Growth and precocious puberty.
Chaussain JL; Couprie C; Lacaille F; Simon D; Job JC
Acta Paediatr Scand Suppl; 1988; 347():38-43. PubMed ID: 2978196
[TBL] [Abstract][Full Text] [Related]
17. Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early puberty.
Tuvemo T; Jonsson B; Gustafsson J; Albertsson-Wikland K; Aronson AS; Häger A; Ivarson S; Kriström B; Marcus C; Nilsson KO; Westgren U; Westphal O; Aman J; Proos LA
Acta Paediatr; 2004 Nov; 93(11):1456-62. PubMed ID: 15513572
[TBL] [Abstract][Full Text] [Related]
18. Precocious puberty and statural growth.
Carel JC; Lahlou N; Roger M; Chaussain JL
Hum Reprod Update; 2004; 10(2):135-47. PubMed ID: 15073143
[TBL] [Abstract][Full Text] [Related]
19. Final height after treatment of early puberty in short adopted girls with gonadotrophin releasing hormone agonist with or without growth hormone.
Mul D; Oostdijk W; Waelkens JJ; Drop SL
Clin Endocrinol (Oxf); 2005 Aug; 63(2):185-90. PubMed ID: 16060912
[TBL] [Abstract][Full Text] [Related]
20. Final adult height in "early normal pubertal girls" treated with gonadotropin releasing hormone agonists.
Wacharasindhu S; Srivuthana S; Aroonparkmongkol S; Supornsilchai V; Hiranrat P; Yodvisitsak V
J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S170-3. PubMed ID: 12929985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
